The disease can be treated with antibiotics. However, there is emergence of drug-resistant strains which have made the disease more difficult to treat. Pneumococcal pneumonia is also recognized as an important co-infection of Influenza.
Pneumococcal vaccines Prevenar 13 and Pneumovax 23
There are over 90 different serotypes of Pneumococcus. The 13-valent vaccine (Prevenar 13) is a conjugate vaccine that is suitable for young children (<2 years old), high risk patients (2 years old or above) and the elderly (65 years old or above). The 23-valent vaccine (Pneumovax 23) is a polysaccharide vaccine. It covers an additional 10 serotypes that are not covered by Prevenar 13. Vaccine authorities now recommend the 23 valent vaccine for high risk group patients as it has a broader coverage of serotypes. However the 23-valent vaccine is not suitable for infants and young children. The vaccines are given in 1 to 4 doses depending on the age of recipient and individual vaccine history. Please consult our doctors for details.
Other serious side effects (<0.1 percent): rare, seizure, severe hypersensitivity reactions
Please call our staff at 2526 6332 for information.